Raquel S. D. V. D.
- Country
- Spain
- Department
- Neurology
Research Overview
- A Phase 1, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecal ALN-5288 in Adults with Alzheimer’s Disease
- Efficacy and Safety Evaluation of Latozinemab in Patients with Frontotemporal Dementia Due to Progranulin Gene Mutations: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Phase 1/2 Multicenter Study Evaluating Safety and Efficacy of AVB-101 via Bilateral Intrathalamic Infusion in Frontotemporal Dementia with Progranulin Mutations
Data & Insights
Has run more than one trial at 17 of 59 partner sites.
Specializations
Neurological and Neurodegenerative Disorders
Raquel Sanchez is involved in clinical research across a broad range of neurological diseases, with a clear focus on conditions affecting cognition, movement, and brain function. Her trial portfolio includes studies in Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease, progressive supranuclear palsy, and multiple sclerosis, reflecting sustained interest in chronic and progressive disorders of the central nervous system.
- Alzheimer’s disease
- Parkinson’s disease
- Frontotemporal dementia
- Multiple sclerosis
Her work also extends to epilepsy, migraine, narcolepsy, and other neurocognitive disorders, supporting therapeutic development in both degenerative and symptomatic neurological care.
Breast Cancer and Hormone-Driven Malignancies
Her clinical research includes a substantial emphasis on breast cancer, particularly hormone receptor-positive, HER2-negative, HER2-positive, and triple-negative breast cancer. She is also involved in studies addressing advanced breast cancer, early breast cancer, and biomarker-defined subtypes linked to PIK3CA, BRCA, and homologous recombination repair alterations.
- Hormone receptor-positive breast cancer
- HER2-positive breast cancer
- Triple-negative breast cancer
- Early breast cancer
Her portfolio also covers related endocrine-sensitive and metastatic solid tumours, including ovarian cancer and endometrial cancer, with interest in precision oncology strategies.
Thoracic and Genitourinary Oncology
Raquel Sanchez is active in trials for non-small cell lung cancer, small cell lung cancer, and other advanced thoracic malignancies, including molecularly defined subgroups such as EGFR-mutated, ALK-positive, RET fusion-positive, and KRAS G12C-mutant disease. Her oncology interests also span head and neck squamous cell carcinoma, gastric cancer, and biliary tract cancer.
- Non-small cell lung cancer
- Small cell lung cancer
- Urothelial carcinoma
- Renal cell carcinoma
She is additionally involved in urothelial carcinoma, renal cell carcinoma, and prostate cancer, covering both localized and metastatic disease settings.
Hematologic Malignancies and Cellular Therapies
Her research landscape includes multiple hematologic malignancies, with activity in acute myeloid leukemia, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, mantle cell lymphoma, multiple myeloma, and Waldenström macroglobulinemia. This area also includes studies in myelodysplastic syndromes and myelofibrosis.
- Acute myeloid leukemia
- Diffuse large B-cell lymphoma
- Multiple myeloma
- Myelofibrosis
Her trial involvement further reaches cell therapy and immunotherapy approaches in relapsed or refractory blood cancers, supporting innovation in advanced hematologic treatment.
Cardiometabolic, Inflammatory, and Organ-Specific Diseases
Raquel Sanchez also contributes to clinical research in cardiovascular disease, heart failure, atrial fibrillation, and myocardial infarction, alongside studies in chronic kidney disease, kidney transplantation, and pulmonary hypertension. Her work reflects interest in multisystem disease management and organ protection.
- Cardiovascular disease
- Chronic kidney disease
- Pulmonary hypertension
- Kidney transplantation
She is also involved in trials for autoimmune diseases, inflammatory bowel disease, primary biliary cholangitis, chronic liver disease, and metabolic disorders such as diabetes and obesity.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.